A novel paradigm for immunity and vaccine development against group A streptococcus [ 2014 - 2016 ]

Research Grant

Researchers: Prof Andrew Steer (Principal investigator) ,  Dr Joseph Kado ,  Dr Martina Sanderson-Smith ,  Dr Pierre Smeesters ,  Prof James Dale
View all 6 related researchers

Brief description Serious disease caused by the group A streptococcus (GAS) is responsible for more than 500,000 deaths per year. With no effective control strategies available, a vaccine is urgently needed. One vaccine shows great promise, but there are concerns it may not cover all GAS strains. Our project aims to show that the vaccine may in fact have very broad coverage because of cross-protection between strains using natural immunity model, and may lead to a new paradigm in understanding of GAS immunity.

Funding Amount $AUD 491,229.44

Funding Scheme Project Grants

Notes Standard Project Grant